3631 results for «211»

Filter By

3631 results

Update on renal denervation

16 May 2023 – From EuroPCR 2023

Check out these slides if you want to refresh your memory regarding this session presenting an update on renal denervation.

Renal denervation procedures

Valve-in-valve - LIVE case

17 May 2023 – From EuroPCR 2023

Study the case of a 76-year-old female patient with BMI 32, atrial fibrillation, diabetes, mid chronic kidney disease and history of aortic stenosis, whose Perimount Magna Ease 21 (mismatch) surgical bioprosthesis, implanted in 2016, degenerated, with preserved left ventricular function. 

An Evolut Pro 26 was implanted in...

Valve-in-valve - LIVE case

What's new in 2023 for Nurses and Allied Professionals?

16 May 2023 – From EuroPCR 2023

Longing to revive your memory of this session centered on what’s new for nurses and allied professionals this year? Explore these slides and get a recollect the risks of radiation for staff working in the cath lab.

Nurses and Allied Professionals, what's up in 2023?

Pitfalls during primary PCI in STEMI patients and TAVI procedure

17 May 2023 – From EuroPCR 2023

How should I treat? Explore this series of cases designed to enable you to gain knowledge of techniques for managing unexpected complications during primary PCI, tackle complex anatomical challenges with limited resources, encourage innovation and develop out-of-the-box solutions. In addition, discover effective lifesaving strategies to use...

Pitfalls during primary PCI in STEMI patients and TAVI procedure

Difficult CHIP cases, different approach with different presentation

17 May 2023 – From EuroPCR 2023

Consult this session to explore strategies for managing procedure-related coronary perforation, mastering complex PCI in unplanned scenarios, and optimizing left main bifurcation stenting techniques. Gain valuable insights into the role of imaging in left main PCI, enhancing your diagnostic and interventional skills.

Difficult CHIP cases, different approach with different presentation

Comeback of renal denervation: The ESC Council on hypertension/EAPCI clinical consensus statement

16 May 2023 – From EuroPCR 2023

Ready to rejuvenate your memory of this session tackling on renal denervation? Investigate these slides and review the take home messages.

Renal denervation: consensus and recommendations

Contemporary management of patients with INOCA: a practical guide

17 May 2023 – From EuroPCR 2023

Enrich your understanding of ischemia with non-obstructive corona arteries (INOCA) by watching this very practical session, where you'll discover precious knowledge on the prevalence and causative factors of this condition. Dive into the diagnosis algorithm used for INOCA and explore the latest advancements in its management.

Contemporary management of patients with INOCA: a practical guide

CTO: more than just a procedure

16 May 2023 – From EuroPCR 2023

You might be interested in reviewing the key messages of this session focusing on CTO…Browse these slides and review in particular the fundamentals about characteristics of the CTO patients, treatment goals and NAPS role in CTO treatment.

Coronary total occlusion procedures

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.

04 Mar 2024

Didn’t find what you were looking for?